Union Spring Pharmaceuticals logo

Union Spring Pharmaceuticals

North America, Kentucky, United States, Union Star

Description

Union Springs Pharmaceuticals (USP) is a specialty company that licenses, develops and commercializes over-the-counter (OTC) products.

Investor Profile

Union Spring Pharmaceuticals has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Union Spring Pharmaceuticals frequently co-invest with?

Blue Chip Venture Company
North America, Ohio, United States, Cincinnati
Co-Investments: 1
PB
North America, New York, United States, New York
Co-Investments: 1
AIG Investments
North America, New York, United States, New York
Co-Investments: 1
HealthCare Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Essex Woodlands Healthcare Partners
North America, California, United States, Palo Alto
Co-Investments: 1
Silver Point Capital, L.P.
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Longitude Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Aisling Capital
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Union Spring Pharmaceuticals?

Xanodyne

Newport, Kentucky, United States

Xanodyne Pharmaceuticals is an integrated specialty pharmaceutical company focused on women’s healthcare and pain management.

BiotechnologyHealth CarePharmaceutical
Series UnknownOct 30, 2009
Amount Raised: $87,783,861